Tissue‐type plasminogen activator (tPA) homozygous Tyr471His mutation associates with thromboembolic disease
MedComm · 2023-10 · 4 (5)
DOI: 10.1002/mco2.392 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm, online erschienen am 05.10.2023. Verfasst von Yanyi Tao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hematology Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Tissue‐type plasminogen activator (tPA) encoded by PLAT is a major mediator that promotes fibrinolysis and prevents thrombosis. Pathogenetic mutations in PLAT associated with venous thromboembolism have rarely been reported. Here, we report the first case of a homozygous point mutation c.1411T>C (p.Y471H) in PLAT leading to thromboembolic events and conduct related functional studies. The corresponding tPA mutant protein (tPA‐Y471H) and wild‐type tPA (tPA‐WT) were synthesized in vitro, and mutant mice ( PLAT H/H mice) were constructed. The molecular docking and surface plasmon resonance results indicated that the mutation impeded the hydrogen‐bonding interactions between the protease domain of tPA and the kringle 4 domain of plasminogen, and the binding affinity of tPA and plasminogen was significantly reduced with a difference of one order of magnitude. mRNA half‐life assay showed that the half‐life of tPA‐Y471H was shortened. The inferior vena cava thrombosis model showed that the rate of venous thrombosis in PLAT H/H mice was 80% compared with 53% in wild‐type mice. Our data suggested a novel role for the protease domain of tPA in efficient plasminogen activation, and demonstrated that this tPA mutation could reduce the fibrinolysis function of the body and lead to an increased propensity for thrombosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Hematology Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China.
- Department of Critical Care Medicine Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China.
ORCID-Profile: Yanyi Tao, Liang V Tang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Tao, Y., Ma, J., Feng, Y., Gao, C., Wu, T., Xia, Y., Cheng, Z., Zhang, Y., Liu, T., Hu, Y., & Tang, L. V. (2023). Tissue‐type plasminogen activator (tPA) homozygous Tyr471His mutation associates with thromboembolic disease. MedComm, 4(5). https://doi.org/10.1002/mco2.392
Vancouver
Tao Y, Ma J, Feng Y, Gao C, Wu T, Xia Y, et al. Tissue‐type plasminogen activator (tPA) homozygous Tyr471His mutation associates with thromboembolic disease. MedComm. 2023;4(5). doi:10.1002/mco2.392
BibTeX
@article{Tao2023,
author = {Tao, Yanyi and Ma, Jiewen and Feng, Yuanzheng and Gao, Chenggang and Wu, Tingting and Xia, Yunqing and Cheng, Zhipeng and Zhang, Yi and Liu, Tingting and Hu, Yu and Tang, Liang V},
title = {Tissue‐type plasminogen activator (tPA) homozygous Tyr471His mutation associates with thromboembolic disease},
journal = {MedComm},
year = {2023},
volume = {4},
number = {5},
doi = {10.1002/mco2.392}
}
EUVIMED